BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 7527738)

  • 1. Increased soluble CD14 serum levels and altered CD14 expression of peripheral blood monocytes in HIV-infected patients.
    Nockher WA; Bergmann L; Scherberich JE
    Clin Exp Immunol; 1994 Dec; 98(3):369-74. PubMed ID: 7527738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated plasma soluble CD14 and skewed CD16+ monocyte distribution persist despite normalisation of soluble CD163 and CXCL10 by effective HIV therapy: a changing paradigm for routine HIV laboratory monitoring?
    Castley A; Berry C; French M; Fernandez S; Krueger R; Nolan D
    PLoS One; 2014; 9(12):e115226. PubMed ID: 25544986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monocyte-activation phenotypes are associated with biomarkers of inflammation and coagulation in chronic HIV infection.
    Wilson EM; Singh A; Hullsiek KH; Gibson D; Henry WK; Lichtenstein K; Önen NF; Kojic E; Patel P; Brooks JT; Sereti I; Baker JV;
    J Infect Dis; 2014 Nov; 210(9):1396-406. PubMed ID: 24813472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential expression of CD163 on monocyte subsets in healthy and HIV-1 infected individuals.
    Tippett E; Cheng WJ; Westhorpe C; Cameron PU; Brew BJ; Lewin SR; Jaworowski A; Crowe SM
    PLoS One; 2011; 6(5):e19968. PubMed ID: 21625498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monocyte cell-surface CD14 expression and soluble CD14 antigen in hemodialysis: evidence for chronic exposure to LPS.
    Nockher WA; Scherberich JE
    Kidney Int; 1995 Nov; 48(5):1469-76. PubMed ID: 8544403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic polymorphisms in the CD14 gene are associated with monocyte activation and carotid intima-media thickness in HIV-infected patients on antiretroviral therapy.
    Yong YK; Shankar EM; Westhorpe CLV; Maisa A; Spelman T; Kamarulzaman A; Crowe SM; Lewin SR
    Medicine (Baltimore); 2016 Aug; 95(31):e4477. PubMed ID: 27495090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-37 Expression Is Increased in Chronic HIV-1-Infected Individuals and Is Associated with Inflammation and the Size of the Total Viral Reservoir.
    Højen JF; Rasmussen TA; Andersen KL; Winckelmann AA; Laursen RR; Gunst JD; Møller HJ; Fujita M; Østergaard L; Søgaard OS; Dinarello CA; Tolstrup M
    Mol Med; 2015 Apr; 21(1):337-45. PubMed ID: 25879630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of soluble CD 14 and neopterin as serum parameters of the inflammatory activity of pulmonary sarcoidosis.
    Homolka J; Lorenz J; Zuchold HD; Müller-Quernheim J
    Clin Investig; 1992 Oct; 70(10):909-16. PubMed ID: 1280495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LPS-induced release of IL-1 beta, IL-6, IL-8, TNF-alpha and sCD14 in whole blood and PBMC from persons with high or low levels of HDL-lipoprotein.
    Eggesbø JB; Hjermann I; Lund PK; Joø GB; Ovstebø R; Kierulf P
    Cytokine; 1994 Sep; 6(5):521-9. PubMed ID: 7530060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of CD206 and CD163 on intermediate CD14
    Li X; Du N; Xu G; Zhang P; Dang R; Jiang Y; Zhang K
    Virus Res; 2018 Jul; 253():92-102. PubMed ID: 29857122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated levels of soluble CD14 in serum of patients with systemic lupus erythematosus.
    Nockher WA; Wigand R; Schoeppe W; Scherberich JE
    Clin Exp Immunol; 1994 Apr; 96(1):15-9. PubMed ID: 7512005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble CD163 and soluble CD14 plasma levels but not cellular HIV-DNA decrease during successful interferon-free anti-HCV therapy in HIV-1-HCV co-infected patients on effective combined anti-HIV treatment.
    Parisi SG; Andreis S; Mengoli C; Menegotto N; Cavinato S; Scaggiante R; Andreoni M; Palù G; Basso M; Cattelan AM
    Med Microbiol Immunol; 2018 Aug; 207(3-4):183-194. PubMed ID: 29523966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon-gamma and interleukin-4 down-regulate soluble CD14 release in human monocytes and macrophages.
    Landmann R; Fisscher AE; Obrecht JP
    J Leukoc Biol; 1992 Sep; 52(3):323-30. PubMed ID: 1381744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD14(high)CD16(+) rather than CD14(low)CD16(+) monocytes correlate with disease progression in chronic HIV-infected patients.
    Han J; Wang B; Han N; Zhao Y; Song C; Feng X; Mao Y; Zhang F; Zhao H; Zeng H
    J Acquir Immune Defic Syndr; 2009 Dec; 52(5):553-9. PubMed ID: 19950429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD161+ MAIT cells are severely reduced in peripheral blood and lymph nodes of HIV-infected individuals independently of disease progression.
    Eberhard JM; Hartjen P; Kummer S; Schmidt RE; Bockhorn M; Lehmann C; Balagopal A; Hauber J; van Lunzen J; Schulze zur Wiesch J
    PLoS One; 2014; 9(11):e111323. PubMed ID: 25369333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of LDL and acetylated LDL endocytosis by mononuclear cells in HIV infection.
    Juompan L; Puel J; Fournié GJ; Benoist H
    Biochim Biophys Acta; 1995 Aug; 1272(1):21-8. PubMed ID: 7545009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nef protein of human immunodeficiency virus and lipopolysaccharide induce expression of CD14 on human monocytes through differential utilization of interleukin-10.
    Creery D; Angel JB; Aucoin S; Weiss W; Cameron WD; Diaz-Mitoma F; Kumar A
    Clin Diagn Lab Immunol; 2002 Nov; 9(6):1212-21. PubMed ID: 12414752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of monocyte-macrophage activation markers upon anti-CD4 treatment. Decreased levels of IL-1, IL-6, neopterin and soluble CD14 in patients with rheumatoid arthritis.
    Horneff G; Sack U; Kalden JR; Emmrich F; Burmester GR
    Clin Exp Immunol; 1993 Feb; 91(2):207-13. PubMed ID: 7679058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-4 decreases the expression of the monocyte differentiation marker CD14, paralleled by an increasing accessory potency.
    Ruppert J; Friedrichs D; Xu H; Peters JH
    Immunobiology; 1991 Aug; 182(5):449-64. PubMed ID: 1717365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolonged interferon-gamma application by subcutaneous infusion in cancer patients: differential response of serum CD14, neopterin, and monocyte HLA class I and II antigens.
    Landmann R; Ludwig C; Wesp M; Fisscher A; Obrist R; Knüsli C; Denz H; Obrecht JP
    J Interferon Res; 1992 Apr; 12(2):103-11. PubMed ID: 1374454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.